Cardiac arrhythmias in women;Arritmias cardiacas en la mujer

Revista Espanola de Cardiologia

Volumn 59, Issue 6, 2006, Pages 609-618

  Bernal, Oscar ^a   Moro, Concepción ^a  

^a UNIVERSITY OF ALCALÁ   (Spain)

Author keywords

Arrhythmia; Sudden death; Woman

Indexed keywords

ATRIOVENTRICULAR BLOCK; BRUGADA SYNDROME; CARDIAC RESYNCHRONIZATION THERAPY; CAROTID SINUS SYNDROME; CLINICAL FEATURE; DEFIBRILLATION; EVIDENCE BASED MEDICINE; FEMALE; HEART ARRHYTHMIA; HEART ATRIUM FIBRILLATION; HEART ELECTROPHYSIOLOGY; HEART RATE; HEART VENTRICLE FIBRILLATION; HEART VENTRICLE TACHYCARDIA; HUMAN; LONG QT SYNDROME; MALE; PREVALENCE; PUBLICATION; QRS COMPLEX; QT INTERVAL; REENTRY TACHYCARDIA; REVIEW; SEX DIFFERENCE; SICK SINUS SYNDROME; SINUS TACHYCARDIA; SUDDEN DEATH; SUPRAVENTRICULAR TACHYCARDIA; WOLFF PARKINSON WHITE SYNDROME;

EID: 33746970309     PISSN: 03008932     EISSN: None     Source Type: Journal    
DOI: 10.1157/13089748     Document Type: Article

References (76)

1. Bazett HC. An analysis of the time-relations of electrocardiograms. Heart. 1920;7:353-70.
2. Liu K, Ballew C, Jacobs DR Jr, Sidney S, Savage PJ, Dyer A, et al. Ethnic differences in blood pressure, pulse rate, and related characteristics in young adults. The CARDIA study. Hypertension. 1989;14:218-26.
3. Burke JH, Goldberger JJ, Ehlert FA, Kruse JT, Parker MA, Kadish AH. Gender differences in heart rate before and after autonomic blockade: evidence against an intrinsic gender effect. Am J Med. 1996;100:537-43.
4. Villareal RP, Woodroof AL, Massumi A. Gender and cardiac arrhythmias. Tex Heart Inst J. 2001; 28:265-275.
5. James AF, Choosy SC, Hancox JC. Recent advances in understanding sex differences in cardiac repolarization. Prog Biophys Mol Biol. 2005. Disponible en: www.sciencedirect.com
6. Huikuri HV, Pikkujamsa SM, Airaksinen KE, Ikaheimo MJ, Rantala AO, Kauma H, et al. Sex-related differences in autonomic modulation of heart rate in middle-aged subjects. Circulation. 1996;94:122-5.
7. Stramba-Badiale M, Locati EH, Martinelli A, Courville J, Schwartz PJ. Gender and the relationship between ventricular repolarization and cardiac cycle length during 24-h Holter recordings. Eur Heart J. 1997;18:1000-6.
8. Merri M, Benhorin J, Alberti M, Locati E, Moss AJ. Electrocardiographic quantitation of ventricular repolarization. Circulation. 1989;80:1301-8.
9. Rautaharju PM, Zhou SH, Wong S, Calhoun HP, Berenson GS, Prineas R, et al. Sex differences in the evolution of the electrocardiographic QT interval with age. Can J Cardiol. 1992;8:690-5.
10. Okin PM, Roman MJ, Devereux RB, Kligfield P. Gender differences and the electrocardiogram in left ventricular hypertrophy. Hypertension. 1995;25:242-9.
11. Rautaharju P, Kooperberg C, Larson J, Lacroix A. Electrocardiographic abnormalities that predict coronary heart disease events and mortality in postmenopausal women. Circulation. 2006;113: 473-80.
12. Krahn AD, Yee R, Klein GJ, Morillo C. Inappropriate sinus tachycardia: evaluation and therapy. J Cardiovasc Electrophysiol. 1995;6:1124-8.
13. Rodriguez LM, De Chillou C, Schlapfer J, Metzger J, Baiyan X, Van den Dool A, et al. Age at onset and gender of patients with different types of supraventricular tachycardias. Am J Cardiol. 1992;70:1213-5.
14. Benjamin EJ, Levy D, Vaziri SM, D'Agostino RB, Belanger AJ, Wolf PA. Independent risk factors for atrial fibrillation in a population-based cohort. The Framingham Heart Study. JAMA. 1994; 271:840-4.
15. Liuba I, Jonsson A, Safstrom K, Waldfridsson H. Gender related differences in patients with atrioventricular nodal reentry tachycardia. Am J Cardiol. 2006;97:384-8.
16. Pappone C, Vincenzo S. Catheter ablation should be performed in asymptomatic patients with Wolff-Parkinson-White syndrome. Circulation. 2005;112:2207-15.
17. Wolbrette D, Hemantkumar P. Arrhythmias and women. Curr Opinion Cardiol. 1999;14:36-48.
18. Puranik R, Chow CK, Duflou JA, Kilborn MJ, McGuire MA. Sudden death in the young. Heart Rhythm. 2005;2:1277-82.
19. Maurer MS, Shefrin ED, Fley TC. Prevalence and prognostic significance of exercise-induced supraventricular tachycardia in apparently healthy volunteers. Am J Cardiol. 1995;75:788-92.
20. Rosano GM, Panina G. Oestrogens and the heart. Therapie. 1999; 54:381-5.
21. Dagres N, Clague JR, Breithardt G, Borggrefe M. Significant gender-related differences in radiofrequency catheter ablation therapy. J Am Coll Cardiol. 2003;42:1103-7.
22. Go AS, Hylek EM, Phillips KA, Chang Y, Henault LE, Selby JV, et al. Prevalence of diagnosed atrial fibrillation in adults. National implications for rhythm management and stroke prevention: the AntiCoagulaton and Risks Factors in Atrial Fibrillation (ATRIA) Study. JAMA. 2001;285:2370-5.
23. Benjamin EJ, Wolf PA, D'Agostino RB, Silbershatz H, Kannel WB, Levy D. Impact of atrial fibrillation on the risk of death: the Framingham heart study. Circulation. 1998;98:946-52.
24. Feinberg WM, Blackshear JL, Laupacis A, Kronmol R, Hart RG. Prevalence, age distribution and gender of patients with atrial fibrillation. Arch Intern Med. 1995;155:469-73.
25. Fang MC, Singer DE, Chang Y, Hylek EM, Henault LE, Jensvold NG, et al. Gender differences in the risk of ischemic stroke and peripheral emboli: in atrial fibrillation: the Anticoagulation and Risk factors in Atrial fibrillation (ATRIA) study. Circulation. 2005;112:1687-91.
26. Rienstra M, Van Veldhuisen DJ, Hagens VE, Ranchor AV, Veeger NJ, Crijns HJ, et al. Gender related differences in rhythm control treatment in persistent fibrillation: data of the Rate Control versus Electrical Cardioversion. J Am Coll Cardiol. 2005;4: 1298-306.
27. Adams KF, Patterson JH, Gattis WA, O'Connor CM, Lee CR, Schwartz TA, et al. Relationship of serum digoxin concentration to mortality and morbidity in women in the digitalis investigation group trial: a retrospective analysis. J Am Coll Cardiol. 2005;46: 497-504.
28. Haissaguerre M, Jais P, Sha DC, Takahasi A, Hocini M, Quiniou G, et al. Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins. N Engl J Med. 1998;339: 659-66.
29. Hocini M, Jais P, Sanders P, Takahasi A, Rotter M, Rostock Th, et al. Techniques, evaluation and consequences of linear block at the left atrial roof in paroxysmal atrial fibrillation. A prospective and randomized study. Circulation. 2005;112:3688-96.
30. Haissaguerre M, Sanders, Hocini M, Takahasi A, Rotter M, Sacher F, et al. Catheter ablation of long lasting persistent atrial fibrillation. J Cardiovasc Electrophysiol. 2005;16:1125-37.
31. Oral H, Pappone C, Chugh A, Good E, Bogun F, Pelosi F, et al. Circumferential pulmonary vein ablation for chronic atrial fibrillation. N Engl J Med. 2006;354:934-41.
32. Kannel WB, Wilson PW, D'Agostino RB, Cobb J. Sudden coronary death in women. Am Heart J. 1998;136:205-12.
33. Solomon SD, Zelenkofske S, McMurray JV, Finn PV, Velazquez E, Ertl G, et al, for the VALIANT trial investigators. Sudden death in patients with myocardial infarction and left ventricular dysfunction, heart failure or both. N Engl J Med. 2005;352:2581-8.
34. Zheng Z, Croft JB, Giles WH, Mensha GA. Sudden cardiac death in the United states 1989 to 1998. Circulation. 2001;104:2158-63.
35. Albert CM, McGovern BA, Newell JB, Ruskin JN. Sex differences in cardiac arrest survivors. Circulation. 1996;93:1170-6.
36. Cupples LA, Gagnon DR, Kannel WB. Long- and short-term risk of sudden coronary death. Circulation. 1992;85:111-8.
37. Moss AJ, Schwartz PJ, Crampton RS, Tzivoni D, Locati EH, MacCluer J, et al. The long QT syndrome. Prospective longitudinal study of 328 families. Circulation. 1991;84:1136-44.
38. Dittrich H, Gilpin E, Nicod P, Cali G, Henning H, Ross J Jr. Acute myocardial infarction in women: influence of gender on mortality and prognostic variables. Am J Cardiol. 1988;62:1-7.
39. Freedman RA, Swerdlow CD, Soderholm-Difatte V, Mason JW. Clinical predictors of arrhythmia inducibility in survivors of cardiac arrest: importance of gender and prior myocardial infarction. J Am Coll Cardiol. 1988;12:973-8.
40. Vaitkus PT, Kindwall KE, Miller JM, Marchlinski FE, Buxton AE, Josephson ME. Influence of gender on inducibility of ventricular arrhythmias in survivors of cardiac arrest with coronary artery disease. Am J Cardiol. 1991;67:537-9.
41. Moss AJ, Hall WJ, Cannom DS, Daubert JP, Higgins SL, Klein H, et al. Improved survival with an implanted defibrillator in patients with coronary heart disease at high risk of ventricular arrhythmia. N Engl J Med. 1996;335:1933-40.
42. Moss AJ, Zareba W, Hall WJ, Klein H, Wilber D, Cannom DS, et al. The multicenter automatic defibrillator implantation trial II investigators. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med. 2002;346:877-83.
43. Bigger JT. Prophylactic use of implanted cardiac defibrillators in patients at high risk of ventricular arrhythmias after coronary artery graft surgery. CABG Patch trial investigators. N Engl J Med. 1997;337:1569-75.
44. Bristow MR, Saxon LA, Boehmer J, Krueger S, Kass DA, De Marco T, et al. Comparison of medical therapy, pacing and defibrillation in advanced chronic heart failure COMPANION investigators. Cardiac resynchronization therapy with or without implantable defibrillator in advanced chronic heart failure. N Engl J Med. 2004;350:2140-50.
45. Kadish A, Dyer A, Daubert J, Quigg R, Estes NA, Anderson K, et al. Defibrillators in non-ischemic cardiomyopathy treatment evaluation( DEFINITE) investigators. Prophylactic implantation in patients with non-ischemic dilated cardiomyopathy. N Engl J Med. 2004;350:2151-8.
46. Hohnloser SH, Kuck H, Dorian P, Roberts RS, Hampton JR, Hatala R, et al, the DINAMIT investigators. Prophylactic use of an implantable cardioverter-defibrillator after acute myocardial infarction. N Engl J Med. 2004;351:2481-8.
47. Bardy GH, Lee KL, Mark DB, Poole JE, Packer DL, Boineau R, et al. The sudden cardiac death in heart failure trial (SCD HeFT) investigators. Amiodarone or an implantable cardioverter defibrillator for congestive heart failure. N Engl J Med. 2005;352:225-37.
48. The antiarrhythmics versus implantable defibrillator (AVID) investigators. A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. N Engl J Med. 1997;337:1576-83.
49. Kuck KH, Cappato R, Siebels J, Ruppel R. Randomized comparison of antiarrhythmic drug therapy with implantable defibrillators in patients resuscitated from cardiac arrest. Circulation. 2000; 102:748-54.
50. Connolly SJ, Gent M, Roberts RS, Dorian P, Roy D, Sheldon RS, et al. The Canadian Implantable defibrillator study (CIDS): a randomised trial of the implantable cardioverter defibrillator against amiodarone. Circulation. 2000;101:1297-302.
51. Lampert R, McPherson CA, Clancy JF, Caulin-Glaser TL, Rosenfeld LE, Bastford WP. Gender differences in ventricular arrhythmia recurrence in patients with coronary artery disease and implantable cardioverter defibrillator. J Am Coll Cardiol. 2004;43: 2239-99.
52. Zareba W, Moss AJ, Hall J, Wilber DJ, Ruskin JN, McNitt S, et al, for the MADIT-II investigators. Clinical course and implantable cardioverter defibrillator therapy in postinfarction women with severe left ventricular dysfunction. J Cardiovasc Electrophysiol. 2005;16:1265-70.
53. Nakagawa M, Takahashi N, Nobe S, Ichinose M, Ooie T, Yufu F, et al. Gender differences in various types of idiopathic ventricular tachycardia. J Cardiovasc Electrophysiol. 2002;13:633-8.
54. Lamberti F. Gender differences in idiopathic ventricular tachycardia. J Cardiovasc Electrophysiol. 2002;13:639-40.
55. Calkins H. Arrhythmogenic right ventricular dysplasia cardiomyopathy. Curr Opin Cardiol. 2006;21:55-63.
56. Kies P, Boersma M, Bax J, Schalij M, Van der Wall E. Arrhythmogenic right ventricular dysplasia cardiomyopathy: screening, diagnosis and treatment. Heart Rhythm. 2006;3:225-34.
57. Moss AJ, Schwartz PJ, Crampton RS, Tzivoni D, Locati EH, MacCluer J, et al. The long QT syndrome. Prospective longitudinal study of 328 families. Circulation. 1991;84:1136-44.
58. Ebert SN, Liu XK, Woosley RL. Female gender as a risk factor for drug-induced cardiac arrhythmias: evaluation of clinical and experimental evidence. J Women's Health. 1998;7:547-57.
59. Locati EH, Zareba W, Moss AJ, Schwartz PJ, Vincent GM, Lehmann MH, et al. Age- and sex-related differences in clinical manifestations in patients with congenital long-QT syndrome: findings from the International LQTS Registry. Circulation. 1998; 97:2237-44.
60. Lehmann MH, Timothy KW, Frankovich D, Fromm BS, Keating M, Locati EH, et al. Age-gender influence on the rate-corrected QT interval and the QT-heart rate relation in families with genotypically characterized long QT syndrome. J Am Coll Cardiol. 1997;29:93-9.
61. Rashba EJ, Zareba W, Moss AJ, Hall WJ, Robinson J, Locati EH, et al. Influence of pregnancy on the risk for cardiac events in patients with hereditary long QT syndrome. LQTS Investigators. Circulation. 1998;97:451-6.
62. Schwartz PJ, Spazzolini C, Crotti L, Bathen J, Amilie JP, Timothy K, et al. The Jervell and Lange-Nielsen Syndrome. Circulation. 2006;113:783-90.
63. Makkar RR, Fromm BS, Steinman RT, Meissner MD, Lehmann MH. Female gender as a risk factor for torsades de pointes associated with cardiovascular drugs. JAMA. 1993; 270:2590-7.
64. Lehmann MH, Hardy S, Archibald D, Quart B, MacNeil DJ. Sex difference in risk of torsade de pointes with d,1-sotalol. Circulation. 1996;94:2535-41.
65. Pratt CM, Camm AJ, Cooper W, Friedman PL, MacNeil DJ, Moulton KM, et al. Mortality in the Survival With ORal D-sotalol (SWORD) trial: why did patients die? Am J Cardiol, 1998;81: 869-76.
66. Kuhlkamp V, Mermi J, Mewis C, Seipel L. Efficacy and pro-arrhythmia with the use of d,1-sotalol for sustained ventricular tachyarrhythmias. J Cardiovasc Pharmacol. 1997;29:373-81.
67. Woosley RL, Chen Y, Freiman JP, Gillis RA. Mechanism of the cardiotoxic actions of terfenadine. JAMA. 1993;269:1532-6.
68. Drici MD, Knollman BC, Wang WX, Woosley RL. Cardiac actions of erythromycin: influence of female sex. JAMA. 1998;280: 174-6.
69. Reinoehl J, Frankovich D, Machado C, Kawasaki R, Baga JJ, Pires LA, et al. Probucol associated tachyarrhythmic events and QT prolongation: importance of gender. Am Heart J. 1996;131:1184-91.
70. Sarkozy A, Brugada P. Sudden cardiac death and inherited arrhythmia syndromes. J Cardiovasc Electrophysiol. 2005;16:S8-20.
71. Tawan M, Levine J, Mendelson M, Goldberger J, Dyer A, Kadish A. Effect of pregnancy on paroxysmal supraventricular tachycardia. Am J Cardiol. 1993;72:838-40.
72. Wilderhom J, Wilderhom A, Rahimtoola S, Elkayam U. WPW syndrome during pregnancy: increased incidence of supraventricular arrhythmias. Am Heart J. 1992;123:769-98.
73. Brodsky M, Doria R, Allen B, Sato D, Thomas G, Sada M. New onset ventricular tachycardia during pregnancy. Am Heart J. 1992;123:933-41.
74. Liu S, Yuan S, Kongstad O, Olsson SB. Gender differences in the electrophysiological characteristics of atrioventricular conduction system and their clinical implications. Scand Cardiovasc J. 2001; 35:313-7.
75. Brunner M, Olschewski M, Geibel A, Bode C, Zehender M. Long term survival after pacemaker implantation. Eur Heart J. 2004;25: 88-95.
76. Bleeker GB, Schalij MJ, Boersma E, Steendijk P, Van der Wall EE, Bax JJ. Does a gender difference in response to cardiac resynchronization therapy exists? Pacing Clin Electrophysiol. 2005;28:1272-5.